TIME-RELATED CORTICAL AMINO-ACID CHANGES AFTER BASAL FOREBRAIN LESION- A MICRODIALYSIS STUDY

Citation
Ml. Boatell et al., TIME-RELATED CORTICAL AMINO-ACID CHANGES AFTER BASAL FOREBRAIN LESION- A MICRODIALYSIS STUDY, Journal of neurochemistry, 64(1), 1995, pp. 285-291
Citations number
48
Categorie Soggetti
Biology,Neurosciences
Journal title
ISSN journal
00223042
Volume
64
Issue
1
Year of publication
1995
Pages
285 - 291
Database
ISI
SICI code
0022-3042(1995)64:1<285:TCACAB>2.0.ZU;2-X
Abstract
Cholinergic basal forebrain (BF) lesions in experimental animals have been used as a potential model for cholinergic deficits in cortex and hippocampus that occur in normal aging and Alzheimer's disease (AD). G lutamatergic cortical neurons are also affected in AD and could be par t of the neurodegenerative process. In the present study, the effect o f bilateral BF lesion with ibotenic acid microinjection on cortical ex tracellular amino acid levels was determined. Samples were collected e very 20 min with microdialysis probes in awake, freely moving rats und er basal and potassium stimulation conditions and measured by HPLC wit h fluorescence detection. Microdialysis experiments were performed 13 days, 21 days, and 30 days after BF lesion. The effectiveness of the l esion was shown by a significant 30% depletion in acetyl-CoA:choline O -acetyltransferase (EC 2.3.1.6) activity in the frontal cortex. Under basal conditions at 13 days only extracellular levels of taurine (Tau) and Glu were significantly reduced. Tau and Glu levels were recovered after 21 days and 30 days, respectively. In contrast, increase in Gly levels reaches its significance only at 30 days after lesion. Signifi cant increases of Gln levels were observed at 21 days and 30 days. Asp and Ser levels remained constant throughout the period studied. Potas sium stimulation led to increased Asp, Glu, Gly, and Tau levels, where as Gin content decreased and Ser remained unaltered. As Ser is not bel ieved to be a neurotransmitter, its lack of Variation in any of the ex perimental conditions studied supports specific neuronal changes of th e other amino acids. Results are discussed with reference to data obse rved in AD patients and possible mechanisms underlying the changes are suggested.